Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Call Options Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
304Shares Held
60.6MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$390 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$231 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$195 Million2.59% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$101 Million0.11% of portfolio
-
State Street Corp Boston, MA2.15MShares$80.5 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.01B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...